News & Media
News, press releases, statements and other media content about ESGTI.
Rheon Medical’s revolutionary product recognized by the Medtech industry
ESGTI’s Board of Directors have released the 2020 semi-annual reports. The reports are available for download in our download centre.
ESGTI increased its capital by issuing 1,530,000 ordinary shares, resulting in 15,282,935 registered shares issued at CHF 4 per share.
ESGTI AG has completed a debt issuance for an aggregate amount of CHF 83.2 million.
ESGTI AG elected Dimitri Dimitrou, Wolfgang Werlé and Hermann Wirz as new members of the Board of Directors.
ESGTI increased its capital by issuing a maximum number of 16,891,00 registered shares with a nominal value of CHF 1.56 each.
ESG EKO AGRO aquired 100% of the shares of ESG LifeSciences AG.
ESG EKO AGRO Group is now positioned as an ESG investment company.
ESG EKO AGRO AG acquired a significant stake in AltEnergis plc, London.